Currently browsing: Collaborative Achievements

CAC2 Webinar–Landmark Lightings and Proclamations

February 17, 2016
Collaborative Achievements, Webinars No comments yet
In this All-Member webinar for February 2015, CAC2 welcomed presenters Tony Stoddard (Sophia's Fund) and Neal Rourke (International Individual Member). Tony and Neal presented an interactive webinar to encourage dialogue between our members about Landmark Lightings and Proclamations.  They shared their past successes and techniques to help our members reach awareness goals in their communities. Read more

Successful Collaboration: Leveraging an Established Grant Review Process

February 4, 2014
Collaborative Achievements No comments yet
This collaborative research effort was due to childhood cancer groups coming together as part of CAC2. When the founders of Florida-based I Care I Cure Childhood Cancer Foundation approached Jay and Liz Scott of Alex’s Lemonade Stand Foundation at one of the early C3U (now CAC2) meetings, it was the beginning of a productive and fruitful collaboration that has increased the reach of both organizations’ grantmaking. Alex’s Lemonade Stand Foundation (ALSF) has a successful track record of funding cutting-edge medical research – more than 350 projects since 2006. To identify and select the best projects, ALSF has assembled a Scientific [...] Read more

Complete Remission Induced By Dendritic Cell Vaccine For Relapsed Neuroblastoma Patient

August 26, 2013
Collaborative Achievements No comments yet
This collaborative research effort was due to childhood cancer groups coming together as part of CAC2. One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer. Doctors reported this case study in the January 2013 issue of Pediatrics, the journal of the American Academy of Pediatrics, which was funded in part by a joint grant from the Andrew McDonough B+ Foundation, Pierce Phillips Charity and Solving Kids' Cancer. Current treatments for high-risk neuroblastoma patients include chemotherapy, radiation therapy, surgery, stem cell transplant, and immunotherapy. Less than half of the [...] Read more
Archives

Enquire now

Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.